Figure 3
From: The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
Concentration of zinc in plasma (A), gastrocnemius muscle (B) and tumour (C) of mice bearing the MAC16 tumour after 4 days of treatment with PBS, AT, AT plus Zn2+ or Zn2+ alone, as depicted in Figure 1. Differences from PBS controls are shown as *P<0.05 or **P<0.01, whereas differences from AT are shown as †P<0.05 and differences from AT+Zn as ‡P<0.05 or §P<0.01.
